Article
![Hands reaching out Hands reaching out](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/CP02202020.jpg)
Extended-release injectable naltrexone for opioid use disorder
- Author:
- Ashmeer Ogbuchi, MD
- Karen Drexler, MD
- Rachel Gluck, MD
- Karen Hochman, MD
- Yi-lang Tang, MD, PhD
We appreciate the important review by Gluck et al (“Managing patients with comorbid opioid and alcohol use disorders,” Current Psychiatry ,...
Article
![Hands reaching out Hands reaching out](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/CP02202020.jpg)
Managing patients with comorbid opioid and alcohol use disorders
- Author:
- Rachel Gluck, MD
- Karen Hochman, MD
- Yi-lang Tang, MD, PhD
Consider the type and severity of withdrawal symptoms, patients’ goals, and other factors.
Article
![Lab monitoring Lab monitoring](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/CP02109012.jpg)
Laboratory monitoring for patients on buprenorphine: 10 questions
- Author:
- Charlotte Van Hale, MD
- Rachel Gluck, MD
- Yi-lang Tang, MD, PhD
How to best use laboratory testing for patients with opioid use disorder.